Nielsen-Kudsk F
Int J Biomed Comput. 1981 Jan;12(1):83-96. doi: 10.1016/0020-7101(81)90028-3.
The described pharmacokinetic program for TI-59 is in clinical practice applicable in analyses of plasma concentration profiles established after single-dose, intravenous or oral administration of drugs showing one- or two-compartment first-order pharmacokinetics. Analysis of multiple dose, steady state plasma concentration data may also be carried out. Predictions of mean steady state plasma concentrations related to multiple dose drug administration are obtainable on the basis of a preceding single-dose pharmacokinetic analysis. The program contains routines for: exponential regression analysis, determination of and treatment of residuals, simulation of plasma concentration curves, corrections for time-defined intravenous infusion substituting for bolus injection, determination of and correction for lag-time and routines for calculation of fitted and derived pharmacokinetic parameters. Naproxen and theophylline plasma concentration data were used to demonstrate the practical applications of the program.
所描述的TI - 59药代动力学程序在临床实践中适用于分析单剂量静脉注射或口服呈现一室或二室一级药代动力学的药物后所建立的血浆浓度曲线。也可进行多剂量稳态血浆浓度数据的分析。基于先前的单剂量药代动力学分析可获得与多剂量药物给药相关的平均稳态血浆浓度预测值。该程序包含以下例程:指数回归分析、残差的确定与处理、血浆浓度曲线模拟、用定时静脉输注替代大剂量注射的校正、滞后时间的确定与校正以及拟合和导出药代动力学参数的计算例程。使用萘普生和茶碱的血浆浓度数据来证明该程序的实际应用。